Affiner les résultats

Platelet Inhibition in Percutaneous Coronary Interventions = Plättchenhemmung bei perkutanen Koronarinterventionen

Wyss, Christophe ; Roffi, Marco

In: Herz Kardiovaskuläre Erkrankungen, 2005, vol. 30, no. 3, p. 189-196

Erhöhtes Risiko für Stentthrombosen bei DES? = Increased Rate of Stent Thrombosis with DES?

Kaiser, Christoph ; Pfisterer, Matthias

In: Herz Kardiovaskuläre Erkrankungen, 2007, vol. 32, no. 4, p. 296-300

Embolisation von Katheterbeschichtung in das Myokard = Embolization of hydrophilic guide wire coating

Muenst, S. ; Willi, N. ; Cathomas, G. ; Jeger, R.V. ; Soysal, S.D. ; Glatz, K.

Nachbehandlung nach medikamentös beschichteten Stents = Treatment after Drug-Eluting Stent Placement

Eberli, Franz ; Roffi, Marco

In: Herz Kardiovaskuläre Erkrankungen, 2007, vol. 32, no. 4, p. 301-306

Long-term outcomes of fractional flow reserve-guided vs. angiography-guided percutaneous coronary intervention in contemporary practice

Li, Jing ; Elrashidi, Muhamad Y. ; Flammer, Andreas J. ; Lennon, Ryan J. ; Bell, Malcolm R. ; Holmes, David R. ; Bresnahan, John F. ; Rihal, Charanjit S. ; Lerman, Lilach O. ; Lerman, Amir

In: European Heart Journal, 2013, vol. 34, no. 18, p. 1375-1383

SYNTAX score and Clinical SYNTAX score as predictors of very long-term clinical outcomes in patients undergoing percutaneous coronary interventions: a substudy of SIRolimus-eluting stent compared with pacliTAXel-eluting stent for coronary revascularization (SIRTAX) trial

Girasis, Chrysafios ; Garg, Scot ; Räber, Lorenz ; Sarno, Giovanna ; Morel, Marie-Angèle ; Garcia-Garcia, Hector M. ; Lüscher, Thomas F. ; Serruys, Patrick W. ; Windecker, Stephan

In: European Heart Journal, 2011, vol. 32, no. 24, p. 3115-3127

Current concepts on coronary revascularization in diabetic patients

Roffi, Marco ; Angiolillo, Dominick J. ; Kappetein, A. Pieter

In: European Heart Journal, 2011, vol. 32, no. 22, p. 2748-2757

Lack of evidence-based practice leads to major geographical variations in elective coronary revascularization by stents or surgery in England

Carrel, Thierry

In: European Journal of Cardio-Thoracic Surgery, 2015, vol. 47, no. 5, p. 860-861

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Arroyo, Diego ; Togni, Mario ; Puricel, Serban ; Gerard, Baeriswyl ; Sonja, Lehmann ; Corpataux, Noé ; Villeneuve, Hélène ; Boute, Estelle ; Stauffer, Jean-Christophe ; Goy, Jean-Jacques ; Cook, Stéphane

In: Trials, 2014, vol. 15, no. 1, p. 9

Background: Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting stents (BES) have been shown to be superior to first-generation paclitaxel-eluting stents (PES) and second-generation sirolimus-eluting stents (SES). However, neointimal proliferation and very late stent thrombosis is still an unresolved issue of drug-eluting stent (DES) implantation overall. The...

A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations: The CLO-CLO trial = Étude randomisée comparant la réactivité plaquettaire des patients traités par diverses préparations commerciales de clopidogrel. Étude CLO-CLO

Oberhänsli, Markus ; Lehner, Cédric ; Puricel, Serban ; Lehmann, Sonja ; Togni, Mario ; Stauffer, Jean-Christophe ; Baeriswyl, Gérard ; Goy, Jean-Jacques ; Cook, Stéphane

In: Archives of Cardiovascular Diseases, 2012, vol. 105, no. 11, p. 587–592

Objectifs Le but de cette étude est de comparer l’effet sur l’agrégation plaquettaire de la molécule originale de clopidogrel (clopidogrel bisulfate [Plavix®]) aux molécules génériques (clopidogrel besylate [clopidogrel Sandoz®] et clopidogrel hydrochloride [clopidogrel-Mepha®]) et au prasugrel (Efient®). Historique On suspecte que le sel utilisé pour lier la molécule de...